MedTrace Logo

Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue

NCT03305705 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-10-13

No results posted yet for this study

Summary

This study investigates the effect of intravenous iron substitution in non-anaemic premenopausal women with iron deficiency on:

* Changes in the cerebral Dopamine (DA) receptor density after iron substitution, shown by brain PET
* Reduction of fatigue and other neuropsychological symptoms after iron supplementation

Conditions

Interventions

DRUG

Iron Carboxymaltose

Single intravenous infusion within 20 min

DRUG

Sodium chloride 0.9%

Single intravenous infusion of 250 ml within 20 min

Sponsors & Collaborators

  • Albina Nowak, MD

    lead OTHER

Principal Investigators

  • Albina Nowak, MD · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-23
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03305705 on ClinicalTrials.gov